Spark Meditech Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 23-12-2024
- Paid Up Capital ₹ 0.15 M
as on 23-12-2024
- Company Age 22 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 39.80%
(FY 2022)
- Profit -65.11%
(FY 2022)
- Ebitda 24.02%
(FY 2022)
- Net Worth 3.27%
(FY 2022)
- Total Assets 2.22%
(FY 2022)
About Spark Meditech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.15 M, as per Ministry of Corporate Affairs (MCA) records.
Sujatha Pillai, Ramakrishnan Ravindranath, and Vishnu Ravindranath serve as directors at the Company.
- CIN/LLPIN
U51103KL2002PTC015285
- Company No.
015285
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Mar 2002
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Spark Meditech Private Limited offer?
Spark Meditech Private Limited offers a wide range of products and services, including Endoscopy Instruments, Electrotherapy Equipment, Diathermy Machine, Surgical & ICU Equipments, Medical Pumps, Forceps & Graspers, Insufflators, Cautery Machine, Suction Machine, Physiotherapy & Rehab Aids.
Who are the key members and board of directors at Spark Meditech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramakrishnan Ravindranath  | Managing Director | 04-Mar-2002 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vishnu Ravindranath | Director | 01-Aug-2011 | Current |
| Sujatha Pillai | Director | 04-Mar-2002 | Current |
Financial Performance of Spark Meditech.
Spark Meditech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 39.8% increase. The company also saw a substantial fall in profitability, with a 65.11% decrease in profit. The company's net worth moved up by a moderate rise of 3.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Spark Meditech?
In 2019, Spark Meditech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Spark Meditech?
Unlock and access historical data on people associated with Spark Meditech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spark Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spark Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
